CREST OVS helps build trust into mobile and web app development 28 October, 2022 CREST, the international not-for-profit, membership body representing the global cyber security industry, has announced Across Verticals, Nettitude, Pentest People, Trustwave and VerSprite as the first companies to be awarded accreditation to its OWASP Verification Standard (OVS) program, a quality assurance standard… Read More »
Using Data and Occupant Experience to Create Healthier, Safer and More Productive Offices and Workspaces. DUBLIN, Ireland – Ethos, one of EMEA’s leading providers of Data Centre Mechanical and Electrical Design Consultancy, sustainable commercial and smart fit-out buildings, today announced it is the first business in the world to achieve the WELL Performance Rating through… Read More »
12.18. Group and Engel & Völkers Asset Management launch the first fund specialised in tourism real estate for institutional investors The founding portfolio consists of three properties of 12.18. in Ibiza, Sardinia and in Scotland Further joint hospitality purchases for the fund in strategic cooperation with 12.18. are planned The independent license partner Engel &… Read More »
Hamburg, December 2021. ChessBase, the world leading chess software company, announces the auction of a unique collection of currently 14 artworks with the chess world champions. Each champion’s artwork is a unique 1080 x 1080 px GIF showing the notation of one of his most famous games, a ray traced 3D rendering of the key… Read More »
Merck & Co. is adding yet another immuno-oncology first under Keytruda’s belt. But the breadth of the win comes out less than ideal. The FDA has backed Keytruda’s use alongside chemotherapy, with or without Roche’s Avastin, for treating patients with persistent, recurrent or metastatic cervical cancer but only for those whose tumors express the PD-L1… Read More »
[unable to retrieve full-text content]SANTA MONICA, Calif.–(BUSINESS WIRE) October 01, 2021 — Kite, a Gilead Company (Nasdaq: GILD), today announced the U.S. Food and Drug Administration (FDA) has granted approval for Tecartus® (brexucabtagene autoleucel) for the treatment of… Drugs.com – New Drug Approvals